Inside the Healing Dashboard for Brand Partners: Real Usage, Reapplications, and…

Most wound care manufacturers learn how a product actually performs in the field months after the fact — through claims data, sales anecdotes, and the occasional chart audit. Brand partners inside the WoundScribe Product Catalog see it as it happens through the healing dashboard.

The four intelligence layers partners see

• Real usage — which clinicians selected your product, on which wound phenotypes, and at what point in the healing trajectory.
• Reapplication patterns — how often the product is reapplied, at what interval, and how that correlates with progressing, stalled, or declining wounds.
• Wound-type demand — market share by phenotype (venous, arterial, pressure, diabetic foot) surfaced across the network.
• Claim health — denials and rework tied to your product's indications, pulled from WISER claims and compliance so rationale and codes stay attached to every case.

Why this matters more than downstream data

Claims databases tell you what got billed. The healing dashboard tells you what got chosen at the point of care, on which wound, alongside which alternatives, and whether the wound then progressed. That is the signal product and medical teams actually need to prioritize new indications, refine detail aids, and forecast demand.

How the data reaches you

The dashboard is scoped to your product's activity — you never see other manufacturers' cases and clinicians never see who is watching. Data is aggregated and de-identified in line with WoundScribe's clinical governance. Your team receives a recurring cut aligned to the phenotypes and use cases configured during the Product Catalog Launch.

Where it fits with the rest of the catalog

The dashboard closes the loop opened by the encounter flow described in the WoundScribe Product Catalog overview. Configuration decides where your product surfaces; the dashboard shows what happened next.